• Lilly Announces Agreement To Acquire ARMO BioSciences pharmafocusasia
    May 14, 2018
    Eli Lilly and Company and ARMO BioSciences, Inc. announced a definitive agreement for Lilly to acquire ARMO for $50 per share, or approximately $1.6 billion, in an all-cash transaction.
PharmaSources Customer Service